Intercure Ltd (INCR)

$1.77

+0.02

(+1.14%)▲

Live

Performance

  • $1.73
    $1.78
    $1.77
    downward going graph

    2.26%

    Downside

    Day's Volatility :2.81%

    Upside

    0.56%

    downward going graph
  • $0.99
    $3.72
    $1.77
    downward going graph

    44.07%

    Downside

    52 Weeks Volatility :73.39%

    Upside

    52.42%

    downward going graph

Returns

PeriodIntercure LtdIndex (Russel 2000)
3 Months
-28.86%
0.0%
6 Months
-30.83%
0.0%
1 Year
57.66%
0.0%
3 Years
-74.0%
-23.0%

Highlights

Market Capitalization
81.3M
Book Value
$9.64
Earnings Per Share (EPS)
-0.38
Wall Street Target Price
33.86
Profit Margin
-24.07%
Operating Margin TTM
8.2%
Return On Assets TTM
-0.24%
Return On Equity TTM
-13.61%
Revenue TTM
272.7M
Revenue Per Share TTM
5.89
Quarterly Revenue Growth YOY
-38.6%
Gross Profit TTM
102.6M
EBITDA
3.0M
Diluted Eps TTM
-0.38
Quarterly Earnings Growth YOY
-0.85
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Intercure Ltd(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1812.99%

Current $1.77
Target $33.86

Technicals Summary

Sell

Neutral

Buy

Intercure Ltd is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Intercure Ltd
Intercure Ltd
-0.57%
-30.83%
57.66%
-74.0%
-74.07%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
0.22%
-11.71%
9.36%
13.47%
21.32%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
-5.08%
20.69%
22.01%
36.17%
36.17%
Zoetis Inc.
Zoetis Inc.
-0.16%
32.8%
16.08%
-7.35%
52.85%
Viatris Inc.
Viatris Inc.
2.53%
4.53%
31.84%
-16.06%
-28.03%
Catalent, Inc.
Catalent, Inc.
0.9%
7.56%
42.8%
-54.43%
23.98%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Intercure Ltd
Intercure Ltd
22.0
NA
NA
0.0
-0.14
0.0
NA
9.64
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
35.55
35.55
0.27
4.54
0.16
0.12
NA
24.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
32.52
32.52
1.5
0.39
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
37.9
37.9
2.64
5.83
0.49
0.14
0.01
10.94
Viatris Inc.
Viatris Inc.
224.4
NA
0.07
2.67
-0.03
0.03
0.04
16.36
Catalent, Inc.
Catalent, Inc.
211.02
NA
3.02
0.2
-0.25
0.0
NA
19.91
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Intercure Ltd
Intercure Ltd
Buy
$81.3M
-74.07%
22.0
-24.07%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$11.9B
21.32%
35.55
16.0%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$45.6B
36.17%
32.52
9.66%
Zoetis Inc.
Zoetis Inc.
Buy
$87.6B
52.85%
37.9
26.29%
Viatris Inc.
Viatris Inc.
Hold
$14.0B
-28.03%
224.4
-4.24%
Catalent, Inc.
Catalent, Inc.
Hold
$10.9B
23.98%
211.02
-23.81%

Insights on Intercure Ltd

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 106.17M → 62.86M (in $), with an average decrease of 15.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -33.52M → 716.5K (in $), with an average increase of 2389.7% per quarter

  • Vs NBIX

    In the last 3 years, Intercure Ltd has experienced a drawdown of -74.0%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 19.6%

Company Information

intercure (dba canndoc) (nasdaq: incr) (tsx: incr.u) (tase: incr) is the leading, profitable, and fastest growing cannabis company outside of north america. canndoc, a wholly owned subsidiary of intercure, is israel’s largest licensed cannabis producer and one of the first to offer good manufacturing practices (gmp) certified and pharmaceutical-grade medical cannabis products. intercure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of north america. for more information, visit: http://www.intercure.co.

Organization
Intercure Ltd
Employees
270
CEO
Mr. Alexander Rabinovich
Industry
Miscellaneous

Discover More

FAQs